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Abstract
The pathogenesis of edema after traumatic brain injury is complex including the 
destruction of micro-vessels and alterations in microcirculation around the pri-
mary injury and leakage of plasma constituents into the tissue, due to permeability 
changes of the vessel walls. Many functional molecules like histamine, serotonin, 
arachidonic acid, prostaglandins and thromboxane have been shown to induce 
blood–brain barrier (BBB) disruption or cell swelling. It is believed that released 
5-HT binds to 5-HT2 receptors stimulating cAMP and prostaglandins in vessels that 
cause more vesicular transport in endothelial cells leading to serum component’s 
extravasation. The additional amount of serotonin into the tissue due to injury 
maintains the state of increased vascular permeability that ultimately causes edema. 
Serotonin is clearly involved in early cytotoxic edema after TBI. Reduction of 
serotonin in the nervous tissue reduces swelling and the milder cell changes in the 
brain or spinal cord of traumatized rats. Inhibition of serotonin synthesis before 
closed head injury (CHI) in rat models or administration of serotonin antiserum 
after injury attenuates BBB disruption and brain edema volume swelling, and brain 
pathology. Maintaining low serotonin levels immediately after injury may show 
neuroprotection and combat various secondary outcomes that occur after traumatic 
brain injury.
Keywords: TBI, 5-HT (5-Hydroxytryptamine), cerebral edema, BBB permeability, 
brain damage, neuroprotection
1. Introduction
Traumatic brain injury (TBI), the principal cause of morbidity and mortality is a 
serious medical problem in people under 40 years of age. As a major cause of death, 
it is a major worldwide concern and due to lifetime disability it also puts a huge 
burden on society. [1] Despite the scale of this public health crisis, no effective TBI 
therapies currently exist. [2] The hope for effective treatment is derived from the 
fact that much of the post-traumatic damage to the injured brain is caused by a sec-
ondary injury cascade of consecutive pathophysiological events, including opening 
of the blood–brain barrier (BBB), formation of edema, excitotoxicity, inflammatory 
response activation, oxidative stress and ultimately cell death, which exacerbates 
the primary injury. [3] While a variety of factors lead to elevated TBI-related mor-
tality and morbidity, the occurrence of cerebral edema with brain swelling remains 
the most important outcome that contributes to morbidity and mortality. [4] In the 
first week after traumatic brain injury, considering the prevalence of cytotoxic (or 
cellular) edema, brain swelling can only occur with the addition of water from the 
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vasculature to the cranial vault. As such, blood–brain barrier permeability control 
has been a subject of recent research that aims to treat brain edema. [4] Many 
functional molecules like histamine, serotonin, arachidonic acid, prostaglandins 
and thromboxane have been shown to induce BBB disruption or cell swelling. It is 
believed that released 5-HT binds to 5-HT2 receptors stimulating cAMP and prosta-
glandins in vessels that cause more vesicular transport in endothelial cells and also 
leading to serum components extravasation. [5]
It is well known that serotonin (5-hydroxytryptamine, 5-HT) is involved in 
emotional disorders, such as depression and schizophrenia [6]. 5-HT has a role in 
cerebral edema after TBI [7]. Serotonin has been reported to increase nitrogenoxide 
(NO) tissue levels, and NO contributes to inflammation by increasing vascular 
permeability, which leads to edema formation [8, 9]. Activation of the 5-HT2B 
receptor induces endothelium-dependent NO release [10]. Increased calcium levels 
in endothelium lead to NO formation through the eNOS pathway, followed by a 
cGMP-dependent mechanism to increase vascular permeability. [11] Therefore, it 
seems likely that 5-HT may play a significant role in edema after traumatic insults 
to the brain. Therefore, in the present chapter the role of endogenous 5-HT in BBB 
breakdown and in edema formation is discussed as a pharmacological approach to 
alleviate cerebral edema after TBI.
2. Pathophysiology of cerebral edema
After brain injury, secondary complications like cerebral edema are a pressing 
medical problem and can increase mortality to nearly 80% if severe [12]. Cerebral 
edema and brain swelling are estimated to account for up to 50% of patient mor-
tality following traumatic brain injury [4]. Cerebral edema is now understood 
to develop in stages, where each stage is marked by distinct morphological and 
molecular changes [13]. Minutes after acute central nervous system (CNS) injury, 
cytotoxic edema or cellular swelling manifests itself. After cytotoxic edema, ionic 
edema, an extracellular edema that arises in the presence of an intact blood brain 
barrier (BBB), forms immediately. Hours after the initial insult, vasogenic edema, 
an extracellular edema which involves extravasation of plasma proteins manifested. 
[13] Neurons are considered as fragile cells and cannot survive without support 
from other cell types. So, in addition to provide neuroprotection, a new aim for 
acute brain injury research is to investigate and attenuate mechanisms of endothe-
lial, astrocytic, and microglial dysfunction and, thereby, create an environment 
permissible to neuronal survival. It follows that cerebral edema, a phenomenon 
arising from astrocyte and endothelium dysfunction, is an important subject for 
fundamental research and therapeutic intervention. [13].
The term BBB refers to an organization of different cell types that separates the 
luminal contents of the cerebral vasculature from the brain interstitium. Brain ISF, 
which interacts openly with cerebrospinal fluid (CSF), is designed for neuronal 
activity and differs from blood serum because it includes higher levels of Cl− and 
Mg2+ and lower concentrations of K+, Ca2+ and HCO3− [14]. The Virchow Robin 
space and the astrocyte endfeet that are part of BBB are recognised as important 
anatomical components of the so-called “cerebral glymphatic system” [15]. This 
system is designed to account for CSF movements observed in the healthy brain that 
can operate from the parenchyma to clear solutes such as amyloid beta and promote 
the transport of tiny lipophilic molecules, particularly during sleep. [15–17]
A pathological rise in the water mass contained by the interstitial space of the 
brain is cerebral edema. Cytotoxic edema is swelling of oncotic cells, resulting in 
fluid accumulation intracellular rather than extracellular and is best considered as 
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a precursor to extracellular ionic edema. A mass effect that exerts pressure on the 
surrounding shell of tissue is caused by brain swelling. The rigid enclosure of the 
skull magnifies this pressure rise, which puts an upper limit on the volume to which 
the brain can expand. It exerts mechanical forces on the skull interior as the brain 
swells, thereby increasing intracranial tissue pressure. Capillary lumens collapse 
as tissue pressure reaches capillary pressure, precipitating a feed forward phase 
in which the surrounding shell ischemia induces more edema development and 
further swelling in the next shell. [18]
Two key theories exist about the immediate source of the new water mass 
required for brain swelling. In one theory, water, driven by osmotic forces, travels 
from the capillary lumen into the parenchyma and is transmitted through capil-
lary endothelial cells. In support of the first theory, local blood perfusion status 
is closely correlated with the formation of ionic edema. [19] Magnetic resonance 
imaging (MRI) reveals that edema is first observed in regions of peri-infarction 
that are actively perfused in human stroke. [20] However, acceptance of this theory 
is not universal, as there are doubts about the levels of expression of widely cited 
molecular mechanisms for influx of ions and water via endothelium in the brain 
[21]. A recent explanation of the glymphatic system has led to the formulation of 
a second theory, in which CSF is the immediate source of water and ions. In this 
theory, swelling occurs when the influx of CSF into the parenchyma is increased 
and/or interstitial fluid (ISF)efflux is impaired, a condition that precipitates the 
parenchymatic relative accumulation of ISF [21]. The two theories do not account 
well for the formation of vasogenic edema.
Cytotoxic edema is a premorbid cellular process also known as cellular edema, 
whereby extracellular Na+ and other cations enter into neurons and astrocytes 
and accumulate intracellularly due to failure of energy-dependent mechanisms of 
extrusion. This process takes place following CNS injury in all CNS cell types, but 
is especially prevalent in astrocytes. Astrocyte swelling tends to be a response of 
astrocytes to injury and occurs rapidly following a number of forms of CNS injury, 
including ischemia, trauma, hypoglycemia, epileptic status, and fulminant hepatic 
failure. [14] In the development of cerebral edema and swelling, cytotoxic edema is 
an important initial stage, as it generates the driving force for the influx of ionic and 
vasogenic edema, which induces swelling. As a consequence of primary active trans-
port or secondary active transport, osmolite cellular influx may occur. A continuous 
supply of adenosine triphosphate (ATP) is needed for primary active transport 
to provide energy for “pumps” such as the Na+/K+-ATPase and Ca2+ATPase. [13] 
Secondary active transport utilises the potential energy stored in transmembrane 
ionic gradients that was previously generated through primary active transport. 
Secondary active transporters include ion channels and cotransporters such as the 
Na+/K+/Cl− co-transporter (NKCC) [1, 22] and the Na+/Ca2+ exchanger. After many 
types of CNS injury, intracellular ATP becomes depleted and due to that mechanism 
independent of intracellular ATP, like secondary active transport, are more likely to 
be involved in the formation of ionic edema. [13] NKCC1 is constitutively expressed 
by astrocytes in all region of the adult brain [22–24] In vitro experiments using 
cultured primary astrocytes is shown that NKCC1 leads to cell swelling in conditions 
of high extracellular potassium. [25, 26] In vivo, swelling is decreased by the NKCC1 
inhibitor bumetanide after trauma and ischemia [27–29].
Acute CNS injury activates a program of molecular changes in the neurovascular 
unit before and after transcription that leads to the development of endothelial 
“permeability pores” and subsequent loss of BBB integrity. Based on the key sub-
stances undergoing transcapillary motion, progressive endothelial dysfunction can 
be organised into three stages, i.e. ionic edema, vasogenic edema, and hemorrhagic 
conversion. [13]
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Vasogenic edema is a type of extracellular edema characterized by BBB break-
down, in which a pore of transendothelial permeability develops that allows the 
interstitial brain compartment to extravasation of water and plasma proteins such 
as albumin and IgG. Capillary structural integrity, unlike hemorrhage, is main-
tained during vasogenic edema in such a way that erythrocyte passage is prevented. 
[30] It is thought that the three phases of endothelial dysregulation occur sequen-
tially, although the speed of change between phases possibly depends on the form 
and severity of injury. In addition, since many etiologies of brain endothelial 
dysregulation and cerebral edema are focal in nature, brain tissue typically displays 
a complex spatiotemporal pattern of the various stages of endothelial dysregulation. 
Significant gaps still remain in our understanding of how specific proteins contrib-
ute to cerebral edema. [13]
3. Serotonergic role in development of cerebral edema
In many brain disorders, edema is a severe complication, including traumatic 
injury. Traumatic brain edema pathogenesis is complex and involves physical 
disruption of microvessels, microcirculatory changes in and around the primary 
injury, and changes in the permeability of the vessel walls that contribute to plasma 
constituents leaking into the tissue. [31] There are reasons to assume that many of 
these events are caused by a variety of chemical mediators, such as biogenic amines, 
arachidonic acid, leucotrienes, histamine and free radicals, that are released or 
activated in and around the primary lesion [32]. However, the role of serotonin 
(5-hydroxytryptamine, 5-HT) is not well understood in traumatic brain edema. 
In multiple neurological disorders and in pathological conditions, several lines of 
recent evidence suggest a presumptive function of this amine. [7] Major changes in 
the synthesis of serotonin occur in important brain injuries such as stroke, ischemia 
and trauma, as well as in experimental cold injury lesions and other neurological 
diseases. [7] Increased serotonin content occurs after traumatic brain insults in 
the walls of the cerebral vessels, cerebrospinal fluid and brain. [5] In a wide range 
of psychiatric disorders and mental disturbances, irregular serotonin levels in the 
blood and brain have been identified. [33] In cerebral vessels, serotonergic recep-
tors are present and intracarotid, intravenous or intracerebroventricular serotonin 
infusion substantially affects the cerebral circulation and metabolism as well as 
increasing the permeability of the blood–brain barrier (BBB) [7, 32, 34] Therefore, 
various studies were conducted to examine the function of endogenous 5-HT in 
BBB breakdown, edema formation and early cellular changes in experimental 
models of traumatic brain injury. Therefore, it seems probable that 5-HT could play 
an important role in edema formation and cellular changes following traumatic 
insults to the brain.
Studies show that endogenous depletion of 5-HT before acute insult to the brain 
substantially thwarts the production of edema and early cellular changes, suggesting 
that this amine plays an important role in the pathophysiology of traumatic brain 
injury [35]. Clearly, physical damage to the brain can initiate a cascade of biochemi-
cal and structural events in and around the primary injury. [36] Edema is one of 
those secondary events that may aggravate a primary injury, and studies suggest that 
serotonin could be involved in edema-causing micro vascular reactions [7]. Serotonin 
is present in many neuronal pathways arising from the nuclei of the dorsal raphe and 
leptomeninges mast cells and in blood platelets. [33] Changes in the concentration of 
serotonin most possibly occur during the progression of the injury. At the same time 
as edema is produced, additional quantities of serotonin may be brought in from the 
blood or from neurons. However, biochemical determinations suggest a rise in the 
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serotonin content of the traumatized brain. [37] Serotonin is a powerful chemical 
micro vascular response mediator to cerebral edema. [32] Results of para-chloro-
phenylalanine (pCPA) pretreatment before trauma induction are consistent with the 
notion that serotonin plays a role as a vascular permeability-increasing compound 
that contributes to early edema. [7, 38] Para-chlorophenylalanine (pCPA), acts as 
a selective and irreversible inhibitor of tryptophan hydroxylase, which is a rate-
limiting enzyme in the biosynthesis of serotonin. This is further demonstrated by 
the fact that the degree of cell changes in the periphery of the initial lesion is lower 
in pCPA pretreated rats than in non-treated animals with the same type of injury. 
[7] Therefore, it seems obvious that the decrease in the content of serotonin in the 
nervous tissue is somehow reflected in the decreased swelling and milder changes in 
the brain of traumatized rats. Nevertheless, apart from the effects of serotonin, ara-
chidonic acid release, prostaglandins and thromboxane can synergistically contribute 
to edema formation.
The microdialysis technique was used in the popular carotid artery for intra-
arterial recordings. This new application was found to be a genuinely acceptable 
and effective method that allows direct measurements of HPLC plasma serotonin 
without any further extraction process [39]. Studies show a significant increase in 
downstream plasma serotonin concentrations in response to acute non-occlusive 
common carotid artery thrombosis (CCAT) that appears to be caused solely by 
endothelium photochemical and not photo thermal impact. As a mediator of blood 
brain barrier disturbance and/or irregular cerebral blood flow and/or neuronal 
impairment in ischemic stroke and transient ischemic attacks (TIA’s), the rise in 
serotonin may be of significant importance [39].
3.1 Role of 5-HT2 receptors in formation of edema
5-HT2-receptor antagonists, ketanserin [40] and LY 53857 [41] prevent capsa-
icin-induced mouse ear edema. [42] Antagonists of the 5-HT1-receptor and 5-HT3-
receptor ICS 205–930 and MDL 72222 [43] respectively, had no effect on edema 
caused by capsaicin. [42] The findings clearly indicate that 5-HT is partially involved 
in the development of edema via 5-HT2 receptors. 5-HT is known to induce plasma 
extravasation by direct action on rat microvasculature [44] and to produce vaso-
dilation on peripheral blood vessels through 5-HT1 receptors [44] A recent study 
indicated that endogenous nitric oxide, in addition to 5-HT receptors, is involved in 
a 5-HT-induced increase in vascular permeability in mouse skin. [45] In addition to 
activation of 5-HT2 receptors, 5-HT plays a role of releasing neuropeptides includ-
ing SP as the second mediator of increased vascular permeability at inflammatory 
sites. [46] Mediators like SP, bradykinin and prostaglandins, on the other hand, can 
release tachykinins from primary afferent terminals. [47] Many functional mol-
ecules like histamine, serotonin, arachidonic acid, prostaglandins and thromboxane 
have been confirmed to induce BBB disruption or cell swelling. It is believed that 
released 5-HT binds to 5-HT2 receptors that stimulate cAMP and prostaglandins in 
vessels that cause more vesicular transport in endothelial cells and leading to serum 
components extravasation. The additional amount of serotonin into the tissue due to 
injury maintains the state of increased vascular permeability that ultimately causes 
edema. Changes in serotonin concentration were detected early after focal traumatic 
injury to the rat spinal cord and were associated with edema formation and altera-
tions in blood flow. [35] Compared to controls, the serotonin concentration in the 
traumatised section increased more than 100 percent in five hours after the injury. 
The water content of the traumatised section estimated 5 h after the injury was also 
gradually increased whereas para-chlorophenylalamine, serotonin synthesis inhibi-
tor, impeded the elevation in water content measured 5 h after the trauma. [35]
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3.2 Effect of antibodies to serotonin in closed head injury
Closed head injury (CHI) is a serious clinical issue that leads to immediate death 
for most patients. [48] Swelling of the brain in a closed cranial compartment that 
results in compression of the brain’s vital centers tends to be primarily responsible 
for instant deaths. [49] CNS microhemorrhage, blood–brain barrier (BBB) perme-
ability breakdown, and brain edema development, alone or in combination, are 
primarily responsible for cell damage and long-term neurodegenerative changes 
following CHI. [37, 50, 51] Unfortunately, so far, no effective validated therapies are 
accessible. Efforts to understand the molecular mechanisms of early pathophysi-
ological events in an animal model of CHI are therefore urgently required to explore 
the possible therapeutic potential of different neuroprotective agents in order to 
reduce the development of edema and cell death.
In brain or spinal cord injuries increased plasma and brain levels of serotonin fol-
lowing CHI is seen in previous studies. [50, 51] There was a strong link between this 
rise in tissue serotonin levels and BBB breakdown and edema formation. [52] This 
is further reinforced by the fact that previous inhibition by p-chlorophenylalanine 
(pCPA) of serotonin biosynthesis greatly attenuated the formation of brain edema, 
BBB damage, and cell injury in brain and spinal cord injury. [50, 51, 53] Taken 
together, these findings strongly indicate an important role for serotonin in CNS 
trauma pathophysiology. Subsequent trials of CNS damage using serotonin receptor 
blocker drugs showed controversial results, however. [34, 54, 55] Blocking of 5-HT2c 
and 5-HT1A serotonin receptors improves cognitive function and reduces the forma-
tion of brain edema at low doses. [52, 56, 57], other serotonin receptor antagonists, 
in fact, exacerbated the pathological outcome following brain injury [58, 59] Thus, 
further research is needed into the role of serotonin receptors in mediating brain 
pathology in CNS injuries. Since serotonin has more than seven receptor types with 
several subtypes of receptors [52, 56, 58] There can be no clear view on this topic 
of amine involvement using a few unspecific receptor antagonists. In addition, 
the dosage response and time schedule of drug therapy can further affect the final 
outcome. [60]
Results from studies demonstrate that intracerebroventricular administration of 
monoclonal serotonin antibodies either 30 min before or 30 min after CHI induced 
profound neuroprotection. Therefore, after CHI, marked decreases in BBB disrup-
tion, brain edema formation, and cell injury were noted in serotonin antiserum-
treated animals. Such novel results indicate that early intervention in CHI with 
serotonin antiserum is neuroprotective. [60] Taken together, these findings suggest 
the active participation of this amine during the early stages of CHI, in the cellular 
and molecular pathways of brain edema formation and BBB breakdown. The neuro-
protective effects of antiserum serotonin in CHI are dose-dependent. This indicates 
that to induce neuroprotection, enough serotonin antiserum is required to block in 
vivo brain serotonin. On the other hand, when given 60 min after CHI, even a high 
concentration of serotonin antiserum was ineffective. This means that serotonin 
involvement is important for brain pathology within 30 minutes of CHI. [60]
Elevation in plasma and brain serotonin concentration by intravenous injection 
of serotonin (10 to 20 g/kg/min) in animals without CHI disrupts the BBB func-
tion within 10 min. [52, 59, 60]. This effect of the serotonin on BBB interruption is 
reversible. To measure BBB disruption, many approaches are used. Extravasation 
of Evans blue (EB) dye is the most commonly used procedure. Normally, Evans 
blue does not move through the BBB and hence its presence in brain tissue sug-
gests permeability alterations. Thus, when the same dye was administered 2 to 
3 hours after serotonin administration, BBB permeability to Evans blue dye was no 
longer observed. This means that the dosage and length of exposure to serotonin 
7
Role of 5-HT in Cerebral Edema after Traumatic Brain Injury
DOI: http://dx.doi.org/10.5772/intechopen.96460
play a significant role in development of brain pathology. This principle is further 
confirmed by the prevention of BBB breakdown by previous serotonin synthesis 
inhibition, which attenuated an increase in plasma and brain serotonin in CHI. [60]
BBB permeability breakdown is associated with vasogenic brain edema forma-
tion and cell injury [61–63]. Protein leakage from the vascular compartment via the 
blood–brain interface into the neuronal microenvironment will alter osmotic balance. 
A change in osmotic balance will allow the bulk flow of water from the vascular com-
partment to the cerebral compartments. Furthermore, the release of neurochemical 
mediators of brain edema, e.g. serotonin, prostaglandin, histamine and neuropep-
tides, via particular receptor-mediated pathways, will further affect water transfer 
from blood to the brain. These neurochemicals also cause the BBB process to break 
down. This hypothesis is consistent with a close relationship between the develop-
ment of brain edema, the amount of serotonin and BBB disruption in CHI. [60]
3.3 Serotonergic receptors in brain edema
Tissue collected after ischemic insult in gerbils showed two binding sites for 
ketanserin, one with a lower and one with a higher affinity than that found in 
sham-operated and ischemic animal brains. Ketanserin, a quinazoline derivative, is a 
selective 5-HT2 serotonin receptor antagonist with weak adrenergic receptor block-
ing properties. The results strongly suggest that the properties of binding sites for the 
S2 receptor are altered in ischemia-induced cerebral edema [64]. The demonstrated 
regulation of the binding sites of ketanserin appears to correlate with the observed 
attenuated metabolic rate (= increased release) but not with the abnormal brain 5-HT 
levels. Studies indicate that the variations in 5-HT ischemic patterns are most likely 
related to the type and model of ischemia and/or brain structure examined, as well 
as to the 5-HT detection system used [64] However, in the brains of gerbils subjected 
to 15 min bilateral carotid artery occlusion without recirculation, 5-HT metabolism 
is unquestionably disturbed. [65–67] Therefore, there may be numerous explana-
tions for the lack of apparent changes in the kinetic characteristics of 5-HT2 receptor 
binding sites, especially if the presynaptic region is considered to be the primary site 
of the ischemically disrupted 5-HT pathway. The most critical of these are: (a) the 
insufficient lapse of time (15 min of ischemia) and/or the absence of recirculation 
required for the production of post-synaptic changes; and/or (b) the presence in 
the subcellular compartment of altered 5-HT2 receptor properties obscured by the 
analysis of the entire cortical homogenate rather than the relevant fraction [64].
In neuronal and/or glial and/or vascular postsynaptic membranes, the modified 
5-HT2 receptors may be localized. Desensitization and hypersensitization of the 
receptor sites are demonstrated by the detection of 5-HT2 postsynaptic binding sites 
with lower and higher affinities (indicated by apparent higher KD and lower KD) 
after 1 h of recirculation than those seen in the ischemic and control cortex. Due to 
increased release, reduced uptake and reuptake of 5-HT in the presynaptic regions, 
this could be the result of inappropriately accessible 5-HT at the postsynaptic 
receptor sites. [64] In general, this phenomenon is consistent with the well-known 
agonist-specific desensitization of high levels of hormones and neurohormones 
exposed to cell membranes, whereas their depletion results in supersensitization 
[68]. In addition, in the recovery period (recirculation of 1 and 2 h), the observed 
5-HT2 binding sites with a higher affinity (lower KD) than those seen in ischemic 
and control brains may indicate either an unmasked pre-existing site or an addi-
tional binding site. It can be assumed that the existing disruptions of the 5-HT 
pathway and its adverse effects are not limited to the presynaptic, but also include 
the postsynaptic subcellular compartments, based on the observed changes in the 
properties of S2 receptor binding sites. [64]
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In addition, it is conceivable that the presynaptically released 5-HT into the 
synaptic cleft is also able to directly impact the membrane. In this way, unmetabo-
lized 5-HT overflow can lead to increased permeability of the membrane, allowing 
for more pronounced passive ion transfer and water accumulation in the cells [64]. 
This inference is confirmed by the additional increase in Na+ observed, a decrease 
in K+ concentration and a decrease in Na+-K+-ATPase activity at the time of most 
marked cell swelling. In particular, the concomitant occurrence of changes in the 
kinetic properties of S2 receptors and the activity of Na+K+-ATPase is of concern, 
since an increase in PGF2a levels was also observed after the same period of isch-
emia and recirculation. 5-HT can stimulate the development of PGF2a, since this 
amine increases the formation of PGF1a in cultured cerebrovascular elements. 
Nevertheless, it remains to be clarified if 5-HT affects directly or indirectly Na+K+-
ATPase operation. [64] list Nevertheless, at the time of the most conspicuously 
increased cellular water in the brain of gerbils subjected to ischemia and recircula-
tion, the observed alteration of 5-HT2 receptors strongly supports the argument of 
5-HT involvement in edema formation and/or progression [64].
4. Neuroprotective role of serotonin after TBI
4.1 In cerebral ischemia
The severity of secondary TBI mechanisms depends on the severity of the injury 
or the primary insult location. Reductions in cerebral blood flow [69, 70] have been 
reported to exceed ischemic levels in conditions of extreme TBI. Cerebral ischemia 
is therefore addressed as one secondary cause of injury that may be involved in brain 
trauma. [69, 71] There is a massive increase in the concentration of both excitatory 
and inhibitory neurotransmitters in the extracellular space during cerebral ischemia 
[72–75]. It has been proposed that over-excitation of neurons triggered by excitatory 
amino acid neurotransmitters plays a major role in the pathogenesis of ischemic 
neuronal destruction [76]. Glutamate induces an influx of Ca2+ and Na+ into the 
neuron by acting on N-methyl-D-aspartate (NMDA) and non NMDA receptors. 
The neuronal membrane depolarizes strongly and can allow Ca2+ to reach the cell 
through additional pathways. These events can lead to a neurotoxic accumulation 
of intracellular Ca2+. [77] In addition to glutamate antagonists, agents that induce 
neuronal membrane hyperpolarisation may be able to reduce the influx of Ca2+ via 
these ionophores and may exert neuroprotective effects. 5-HydroxytryptaminelA 
(5-HT1A) receptors through Ca
2+-independent K+-conductance mediate an inhibi-
tory, hyperpolarizing effect on cortical and hippocampal neurons. [78–80] It has 
been shown that 5-HT1A receptor agonists imitate 5-HT’s hyperpolarizing activity on 
the resting membrane potential, increase the firing threshold, and decrease the fir-
ing rate of hippocampal CAl, cortical, and dorsal raphe neurons [81] The complexity 
of 5-HT’s function in cerebral ischemia is probably due to the multiplicity within the 
brain of 5-HT receptors and their distinct distribution and densities. 5-HT1A recep-
tors mediate the inhibitory effect on neurons, as mentioned above. However, 5-HT 
also stimulates hippocampal and cortical neurons via 5-HT2 receptors. [80, 82]
4.2  In neurocognitive and neuropsychiatric disorders following traumatic brain 
injury
Due to variable diagnostic criteria, the prevalence of post-TBI depression 
varies from 6–77% [83], and up to 53% in the first year after injury [84]. The 
association between TBI and the development of neuropsychiatric disorders is 
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well documented. [85, 86] Disruption of the serotonergic system is one unifying 
factor that underlies acquired neuropsychiatric disorders following TBI. As the 
blood–brain barrier cannot be crossed by serotonin, synthesis must occur de novo 
in the brain. The shearing of brain stem axons during TBI effectively interferes with 
pontine and medullary serotonergic projections, resulting in decreased serotonin 
metabolism and production. [87–90] Selective serotonin reuptake inhibitors (SSRIs) 
are a class of antidepressant agents which inhibit serotonin reuptake by presynaptic 
cell monoamine transporters and increase extracellular concentration of serotonin, 
enabling increased serotonin availability in the synaptic cleft and increase activation 
of postsynaptic serotonergic receptors, resulting in increased synaptic signaling. 
SSRIs are involved in regulation of neuronal cell survival and neuroplasticity for 
the treatment of psychiatric disorders, including depression, obsessive–compulsive 
disorder, bulimia, and panic disorder. [91] Serotonin modulates mood, arousal, 
emotion, and working memory, and thus constitute SSRIs an attractive, treatable, 
and potentially long-term pharmacological intervention for neurocognitive and 
neuropsychiatric deficits post-TBI. [92] Consequently, the judicious use of SSRIs in 
post-TBI depression treatment is of great importance and impact.
5. Pharmacological interventions after TBI related to serotonin
A growing number of patients are surviving with residual neurological impair-
ments due to improvements in the treatment of head trauma. A commission of 
the National Institute of Health reports that there are currently 2.5 to 6.5 million 
Americans with TBI-related disabilities [93]. Information from various disciplines 
and professions beginning at the time of injury and continuing through the recovery 
process is required for successful treatment of TBI. In both the sub-acute (less than 
1 month post TBI) and chronic (more than 1 month post TBI) stages, pharmaco-
therapy is used. Selective serotonin reuptake inhibitors (SSRIs) have been found to be 
helpful in the treatment of behavioral syndromes in patients with TBI, especially in 
the sub-acute recovery phases [94], but also in chronic settings. Most studies indicate 
that SSRIs enhance neurobehavioral, neurocognitive, and neuropsychiatric deficits, 
especially agitation, depression, psychomotor retardation, and recent memory loss, 
but most of the information comes from non-randomized studies. Similarly, bupro-
pion boosts the levels of both dopamine and norepinephrine and is a weak serotonin 
reuptake inhibitor. This agent has been effective in treating restlessness at 150 mg per 
day [95] .For anxiety, depressed mood, and deficits in psychomotor pace and recent 
memory, sertraline administered at an average dose of 100 mg daily for 8 weeks was 
found to be beneficial but shorter treatment durations have shown no benefit [94]. 
There was a strong link between the rise in tissue serotonin levels and BBB breakdown 
and edema formation [52]. This is further reinforced by the fact that previous inhibi-
tion by p-chlorophenylalanine (pCPA) of serotonin biosynthesis greatly attenuated 
the formation of brain edema, BBB damage, and cell injury in brain and spinal cord 
injury [53]. Blocking of 5-HT2c and 5-HT1A serotonin receptors improves cognitive 
function and reduces the formation of brain edema at low doses [52, 56]. Thus, 5-HT2 
receptor functions need to be explored more in the development of cerebral edema 
and this can be used as pharmacological intervention to reduce cerebral edema.
6. Conclusion
Due to permeability changes in the vessel walls, the pathogenesis of edema 
after traumatic brain injury is complex, including disruption of micro vessels and 
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changes in microcirculation around the primary injury and leakage of plasma 
constituents into the tissue. To cause BBB disruption or cell swelling, several func-
tional molecules such as histamine, serotonin, prostaglandins and thromboxane 
are involved. The 5-HT released is believed to bind to 5-HT2 receptors stimulat-
ing cAMP and prostaglandins in vessels that trigger further vesicular transport 
in endothelial cells, leading to extravasation of the serum portion. Serotonin is 
involved in early cytotoxic edema after TBI. Reduction of serotonin in the nervous 
tissue is shown to reduce swelling and the milder cell changes in the brain or spinal 
cord of traumatized rats. Inhibition of serotonin synthesis before CHI in rat models 
or administration of serotonin antiserum after injury attenuates BBB disruption 
and brain edema, volume swelling, and brain pathology. BBB disturbance and 
brain edema, volume swelling, and brain pathology are attenuated by inhibition of 
serotonin production before CHI in rat models or the administration of serotonin 
antiserum after injury. Immediately after injury, maintaining low serotonin levels 
can demonstrate neuroprotection and fight various secondary outcomes that occur 
after traumatic brain injury.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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